LIDDS has decided to apply for listing of the company’s shares on Nasdaq Stockholm Main Market in 2021

NEXT STORY
The fluoroscopy equipment market is projected to reach USD 7.5 billion by 2025 from USD 5.9 billion in 2020, at a CAGR of 4.8%
PREV STORY
Polyphor Receives Approval to Start First-in-Human Clinical Trial of Inhaled Antibiotic Murepavadin
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Consistente bevindingen inzake veiligheid en langdurige werkzaamheid na behandeling van reumapatiënten met filgotinib na 84 weken in DARWIN 3 studie

Galapagos presenteert data uit DARWIN 3, andere filgotinibstudies en GLPG1972 van Galapagos op de ...

author_avatar
NASDAQ Market News

Zealand Pharma Presents Financial Results for the First Nine Months of 2021; Provides Updates on Commercial Launch and Timing for Congenital Hyperinsulinism and Short Bowel Syndrome Phase Three Clinical Studies

author_avatar
NASDAQ Market News

Aadi Bioscience to Participate in H.C. Wainwright’s 2nd Annual Precision Oncology Conference 2021

author_avatar
NASDAQ Market News